Pancreatic Transplantation

  • C. F. Barker
  • J. F. Markmann
  • D. C. Dafoe
  • L. J. Perloff
  • A. Naji
Conference paper

Zusammenfassung

Gegenwärtig werden ungefähr dreihundert Pankreastransplantationen pro Jahr durchgeführt, jeweils etwa die Hälfte hiervon in Europa und in Nordamerika. Die Ergebnisse haben sich innerhalb des letzten Jahrzehnts beachtlich verbessert und beginnen sich denen anderer Organtransplantationen zu nähern. Die Einjahresüberlebenschancen der zwischen 1986 und 1988 durchgeführten Fälle liegt bei 56%, während sie für die Pankreastransplantationen zwischen 1978 und 1982 bei nur 20% lag. Der letzte Bericht über die Fälle der Universität von Minnesota ist sehr ermutigend, wonach ein drei Jahre lang funktionierendes Pankreastransplantat ein Fortschreiten der diabetischen Retinopathie verhindert [32].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Barker CF (1975) Experimental clinical transplantation: Pancreas. Transplant Proc 7: 913–914Google Scholar
  2. 2.
    Barker CF, Billingham RE (1977) Immunologically privileged sites. In: Kunkel HG, Dixon FJ (eds) Advances in immunology. Academic, New York, pp 1–54Google Scholar
  3. 3.
    Barker CF, Naji A, Silvers W (1979) Immunological problems in islet transplantation. Diabetes 29: 86–92Google Scholar
  4. 4.
    Bartlett ST, Jennings AS, Yu C, Naji A, Barker CF, Silvers WK (1983) Influence of culturing on the survival of major histocompatibility complex compatible and incompatible thyroid grafts in rats. J Exp Med 157: 348–352PubMedCrossRefGoogle Scholar
  5. 5.
    Bartlett ST, Naji A, Silvers WK, Barker CF (1983) Influence of culturing on the functioning of major histocompatibility complex compatible and incompatible islet grafts in diabetic mice. Transplantation 36: 687PubMedCrossRefGoogle Scholar
  6. 6.
    Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313: 353–360PubMedCrossRefGoogle Scholar
  7. 7.
    Dafoe DC, Campbell DA, Marks WH etal. (1985) Karyotpic chimerism and rejection in a pancreaticoduodenal splenic transplant. Transplantation 40: 472–574Google Scholar
  8. 8.
    D’allesandro AM, Stratta RJ, Sollinger HW, Kalayoolum M, Pirsch JP, Beizer FO (1989) Use of UW solution in pancreas transplantation. Diabetes 38: 7–9CrossRefGoogle Scholar
  9. 9.
    Dubernard JM, Monti LD, Faure JL etal. (1986) Report on 63 pancreas and kidney transplants in uremic diabetic patients. Transplant Proc 18: 1111–1113Google Scholar
  10. 10.
    Dubernard JM, Traeger J, Neyra P etal. (1978) A new method of preparation of segmental pancreatic grafts for transplantation: trials in dogs and in man. Surgery 84: 633PubMedGoogle Scholar
  11. 11.
    Foulis AK, Farquharson MA (1986) Aberrant expression of HLA-DR antigens by insulin containing B-cells in recent onset type I diabetes mellitus. Diabetes 35: 1215–1224PubMedCrossRefGoogle Scholar
  12. 12.
    Gliedman ML, Gold M, Whittaker J etal. (1973) Clinical segmental pancreatic transplantation with ureter-pancreatic duct anastomosis for exocrine drainage. Surgery 74: 171–180PubMedGoogle Scholar
  13. 13.
    Groth CG, Tyden G, Ostman J (1989) Fifteen years experience with pancreas transplantation with pancreaticoenterostomy. Diabetes 38: 13–15PubMedGoogle Scholar
  14. 14.
    Jacobson JD, Markmann JF, Brayman KL, Barker CF, Naji A (1988) Prevention of recurrent autoimmune diabetes in BB rats by anti asialo GMI antibody. Diabetes 37: 838–841PubMedCrossRefGoogle Scholar
  15. 15.
    Kelly WD, Lillehei RC, Merkel FC etal. (1967) Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 61: 827PubMedGoogle Scholar
  16. 16.
    Markmann JF, Brayman KL, Kimura H, Barker CF, Naji A (1989) Prevention of recurrent autoimmune diabetes in BB rats by monoclonal antibody. Diabetes 38: 165–167PubMedGoogle Scholar
  17. 17.
    Markmann JF, Lo D, Naji A, Palmitter RD, Brinter RL, Hebrokaty E (1988) Antigen presenting function of class II MHC expressing pancreatic beta cells. Nature 336: 476–480PubMedCrossRefGoogle Scholar
  18. 18.
    Marliss EB, Nakhooda AF, Poussier P, Sima AAF (1982) The diabetic syndrome of the BB Wistar rat: possible relevance to type I (insulin-dependent) diabetes in man. Diabetologia 22: 225–232PubMedCrossRefGoogle Scholar
  19. 19.
    Murray JE (1982) Reminiscence on renal transplantation. In: Chatterjee SN (ed) Organ transplantation. John Wright, Littleton, pp 1–13Google Scholar
  20. 20.
    Naji A, Barker CF (1984) Animal models of human type I diabetes. In: Gupta S (ed) Immunology of clinical and experimental diabetes. Plenum, New York, pp 91–112Google Scholar
  21. 21.
    Naji A, Barker CF, Silvers WK (1979) Relative vulnerability of isolated pancreatic islets, parathyroid, and skin allografts to cellular and humoral immunity. Transplant Proc 560–562Google Scholar
  22. 22.
    Naji A, Silvers WK, Barker CF (1981) The influence of organ culture on the survival of MHC compatible and incompatible parathyroid allografts in rats. Transplantation 32: 296–298PubMedCrossRefGoogle Scholar
  23. 23.
    Naji A, Silvers WK, Bellgrau D, Barker CF (1981) Spontaneous diabetes in rats: destruction of islets is prevented by immunological tolerance. Science 213: 1390–1392PubMedCrossRefGoogle Scholar
  24. 24.
    Naji A, Silvers WK, Dafoe D, Barker CF (1979) Successful islet transplantation in spontaneous diabetes. Surgery 86: 218–226PubMedGoogle Scholar
  25. 25.
    Nakhooda AF, Like AA, Chappel CI, Murray FT, Marliss EB (1977) The spontaneously diabetic Wistar rat. Metabolic and morphologic studies. Diabetes 26: 100PubMedCrossRefGoogle Scholar
  26. 26.
    Reckard CR, Barker CF (1973) Transplantation of isolated pancreatic islets across strong and weak histocompatibility barriers. Transplant Proc 5: 761–763PubMedGoogle Scholar
  27. 27.
    Roza A, Markmann J, Braymann K, Fox IJ, Naji A, Perloff LJ, Hickey WF, Barker CF (1987) Isolated islet cells are more vulnerable to recurrent diabetes than vascularized pancreas grafts. Surg Forum 38: 373–375Google Scholar
  28. 28.
    Selawry H, Fojaco R, Whittington K (1987) Extended survival of MHC compatible islet grafts from diabetes resistant donors in spontaneously diabetic BB/w rat. Diabetes 36: 1061–1067PubMedCrossRefGoogle Scholar
  29. 29.
    Sibley RK, Sutherland DER, Goethe F, Michael AF (1985) Recurrent diabetes mellitus in the pancreas iso- and allograft. Lab Invest 53: 132PubMedGoogle Scholar
  30. 30.
    Silvers WK, Bartlett ST, Chen HD, Fleming HL, Naji A, Barker CF (1984) Major histocompatibility complex restrictions and transplantation immunity: a possible solution to the allograft problem. Transplantation 37: 28–32PubMedCrossRefGoogle Scholar
  31. 31.
    Sollinger HW, Cook K, Kamps etal. (1984) Experimental experience with pancreaticocys- tostomy for exocrine pancreatic drainage in pancreas transplantation. Transplant Proc 16: 749PubMedGoogle Scholar
  32. 32.
    Sutherland DER, Goetz FC, Kennedy W, Ramsay R, Steffes MW, Mauer MS, Moudry- Munns KC, Dunn DL, Najarian JS (1989) A ten year experience with pancreas (PX) transplantation (TX) in more than 250 patients at a single institution. Ann Surg (in press)Google Scholar
  33. 33.
    Sutherland DER, Moudry KC, Fryd DS (1989) Results of Pancreas-Transplant Registry. Diabetes 38: 46–54PubMedGoogle Scholar
  34. 34.
    Sutherland DER, Moudry KC, Najarian JS (1987) Pancreas transplantation. In: Cerilli J (ed) Organ transplantation and replacement. Lippincott, Philadelphia, pp 535–574Google Scholar
  35. 35.
    Woehrle M, Markmann JF, Armstrong J, Silvers WK, Naji A (1987) Effect of transplant site on islet allograft survival in BB rats. Transplant Proc 19: 925 – 927PubMedGoogle Scholar
  36. 36.
    Woehrle M, Markmann JF, Silvers WK, Barker CF, Naji A (1986) Transplantation of cultured pancreatic islets in BB rats. Surgery 100: 334–340PubMedGoogle Scholar
  37. 37.
    Zinkernagel RM, Doherty PC (1975) H-2 compatibility requirement for T-cell mediated lysis of targets infected with lymphocytic choriomeninigitis virus. J Exp Med 141: 1427–1436PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag · Heidelberg 1990

Authors and Affiliations

  • C. F. Barker
  • J. F. Markmann
  • D. C. Dafoe
  • L. J. Perloff
  • A. Naji

There are no affiliations available

Personalised recommendations